LIMK2 and breast carcinoma: A migration screen based on a phagokinetic track assay identified SRPK1 as a determinant factor in breast cancer metastasis (15); and a separate study demonstrates that the LIM domain kinase 2 (LIMK2) promotes breast cancer metastasis through SRPK1 activation (16).